Not applicableStudy completedNCT03344406What this trial is testingEvaluate Conceptual Saturation of Evaluating Respiratory Symptoms (E-RS) in Subjects With AsthmaWho this might be right forAsthma GlaxoSmithKline 25
Large-scale testing (Phase 3)Study completedNCT02138916What this trial is testingBenralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryWho this might be right forModerate to Very Severe Chronic Obstructive Pulmonary Disease AstraZeneca 1,656
Post-approval studies (Phase 4)Study completedNCT00680056What this trial is testingAdd-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease PatientsWho this might be right forPulmonary Disease, Chronic ObstructiveChronic BronchitisPulmonary Emphysema Federal University of São Paulo 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07519499What this trial is testingPhase II Clinical Study to Evaluate the Efficacy and Safety of XKH001 InjectionWho this might be right forCOPD Zhejiang Kanova Biopharmaceutical Co., LTD 75
Large-scale testing (Phase 3)Not Yet RecruitingNCT06547333What this trial is testingCM310 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary DiseaseWho this might be right forChronic Obstructive Pulmonary Disease CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 884
Testing effectiveness (Phase 2)Study completedNCT02196077What this trial is testingEfficacy and Safety Study of PT009, PT008, and PT005 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)Who this might be right forChronic Obstructive Pulmonary Disease Pearl Therapeutics, Inc. 180
Post-approval studies (Phase 4)Study completedNCT00115492What this trial is testingAdvair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease ExacerbationsWho this might be right forPulmonary Disease, Chronic Obstructive GlaxoSmithKline 797
Not applicableUnknownNCT06142266What this trial is testingFunctional Status in COPD Patients After Exercise Rehabilitation ProgramWho this might be right forCopd Assiut University 120
Testing effectiveness (Phase 2)Study completedNCT01349868What this trial is testingPT005 MDI Dose Ranging Versus Foradil Aerolizer StudyWho this might be right forChronic Obstructive Pulmonary Disease Pearl Therapeutics, Inc. 50
Early research (Phase 1)Study completedNCT02512302What this trial is testingStudy to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).Who this might be right forCOPD Sunovion Respiratory Development Inc. 30
Large-scale testing (Phase 3)Study completedNCT00615030What this trial is testingStudy of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD)Who this might be right forChronic Obstructive Pulmonary Disease (COPD) Novartis 96
Large-scale testing (Phase 3)Ended earlyNCT02685293What this trial is testingStudy to Evaluate the Treatment Effect of PT003 on Cardiovascular Hemodynamics in Subjects With Moderate to Severe COPDWho this might be right forCOPD Pearl Therapeutics, Inc. 4
Testing effectiveness (Phase 2)Ended earlyNCT01006616What this trial is testingLong-Term Study of the Effects of Navarixin (SCH 527123, MK-7123) in Participants With Moderate to Severe COPD (MK-7123-019)Who this might be right forCOPD Merck Sharp & Dohme LLC 616
Testing effectiveness (Phase 2)Study completedNCT01543919What this trial is testingStudy To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium BromideWho this might be right forPulmonary Disease, Chronic Obstructive Pfizer 730
Large-scale testing (Phase 3)Study completedNCT01529632What this trial is testingComparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease (COPD)Who this might be right forChronic Obstructive Pulmonary Disease Novartis Pharmaceuticals 193
Large-scale testing (Phase 3)Study completedNCT01964352What this trial is testingTiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)Who this might be right forPulmonary Disease, Chronic Obstructive Boehringer Ingelheim 813
Large-scale testing (Phase 3)Study completedNCT01490125What this trial is testingThe Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)Who this might be right forChronic Obstructive Pulmonary Disease Novartis Pharmaceuticals 247
Testing effectiveness (Phase 2)Ended earlyNCT00263874What this trial is testingPhase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPDWho this might be right forPulmonary Disease, Chronic Obstructive Pfizer 324
Testing effectiveness (Phase 2)Study completedNCT02109406What this trial is testingEfficacy and Safety Study of Two Dose Levels of AZD2115 in Subjects With Moderate to Severe COPDWho this might be right forChronic Obstructive Pulmonary Disease (COPD) Pearl Therapeutics, Inc. 31
Not applicableUnknownNCT05114434What this trial is testingEffect of BDP/Formoterol/G on Cough Efficacy in Moderate to Severe COPD Patients (EFFICACE)Who this might be right forCOPD, Chronic Obstructive Pulmonary Disease University of Parma 40